Cite Filings / BIAF
Feed Companies Filings Check
Sign in

CIK 0001712762

  • Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465211056
Phone
+1 210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
Filings Financials Insiders Search text
All 403 Financials 149 Shareholder Meetings 16 Executive Compensation 144 Insider Trading 80 Beneficial Ownership Interest 11 Business Combinations 131 Public Offerings 106 Mutual Funds and ETFs 8 Others 49
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-10-23
  3. DEF 14A Proxy Proxy Statement 2026-03-16
  4. DEF 14A Proxy Proxy Statement 2025-11-07
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-10-01
  6. DEF 14A Proxy Proxy Statement 2025-06-02
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-05-14
  8. DEF 14A Proxy Proxy Statement 2024-11-22
  9. DEF 14A Proxy Proxy Statement 2024-09-05
  10. DEF 14A Proxy Proxy Statement 2024-04-15
  11. SC 13G Stake Amended Statement of Ownership 2023-10-10
  12. DEF 14A Proxy Proxy Statement 2023-05-01

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…